Page last updated: 2024-08-23

du-21220 and Erythema

du-21220 has been researched along with Erythema in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ayabe, T; Fuse, Y; Hayashi, T; Higaki, H; Higaki, Y; Kido, K; Kikuchi, A; Matsumoto, S; Sasamori, Y; Shiba, M; Shinozuka, N; Taguchi, A; Umezawa, K	1
Kasamatsu, H; Okamoto, Y; Yamada, T	1

Other Studies

2 other study(ies) available for du-21220 and Erythema

Article	Year
Erythematous and bullous rash strongly indicating toxic epidermal necrolysis associated with the use of intravenous ritodrine hydrochloride. The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:3 Topics: Adrenergic beta-Agonists; Adult; Blister; Cesarean Section; Erythema; Female; Glucocorticoids; Humans; Prednisolone; Pregnancy; Ritodrine; Stevens-Johnson Syndrome; Treatment Outcome	2010
Ritodrine-induced skin rash. Archives of gynecology and obstetrics, 2001, Volume: 264, Issue:4 Topics: Adrenergic beta-Agonists; Adult; Erythema; Female; Humans; Obstetric Labor, Premature; Pregnancy; Ritodrine; Tocolytic Agents	2001

Article

Year

Erythematous and bullous rash strongly indicating toxic epidermal necrolysis associated with the use of intravenous ritodrine hydrochloride.

The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:3

Topics: Adrenergic beta-Agonists; Adult; Blister; Cesarean Section; Erythema; Female; Glucocorticoids; Humans; Prednisolone; Pregnancy; Ritodrine; Stevens-Johnson Syndrome; Treatment Outcome

2010

Ritodrine-induced skin rash.

Archives of gynecology and obstetrics, 2001, Volume: 264, Issue:4

Topics: Adrenergic beta-Agonists; Adult; Erythema; Female; Humans; Obstetric Labor, Premature; Pregnancy; Ritodrine; Tocolytic Agents

2001